期刊文献+

Salusin-β对缺血/再灌注心肌损伤的影响 被引量:2

Effects of salusin-β on heart ischemia-reperfusion injury
下载PDF
导出
摘要 目的:探明salusin-β——一种新发现的心血管调节肽是否具有抗心肌缺血/再灌损伤(RMMI)的作用。方法:以离体灌流大鼠的心脏RMMI为模型,分为对照组和salusin-β预处理组,观察各组大鼠心脏缺血/再灌注(I/R)后的心率(HR)、冠脉流量(CF)和心功能[左室收缩压(LVSP)、左室舒张末压(LVEDP)和左室内压上升、下降速率(±dp/dt)]的变化。结果:以10-8mol/L的salusin-β预处理,可以改善心脏I/R后CF、LVDP、LVEDP、+dp/dt和-dp/dt等指标。10-8mol/L salusin-β组复灌30 min时,CF、LVDP、+dp/dt和-dp/dt的恢复率,分别是停灌前的(52±5)%、(79±8)%、(70±8)%和(69±10)%,显著高于对照组的(45±6)%、(68±10)%、(58±11)%和(57±8)%(P<0.01,n=8)。此外,10-8mol/L salusin-β组复灌30 min时,LVEDP为(28.25±7.62)mmHg,显著低于对照组的(52.52±11.27)mmHg。结论:上述结果表明,salusin-β具有抗心肌RMMI、改善I/R后心脏功能的作用。 AIM: To investigate whether salusin-β, a new regulatory peptide relevant to the cardiovascular system, can alleviate heart ischemia-reperfusion injury. METHODS: The effects of salusin-β on heart rate ( HR), coronary flow (CF) and heart function ( LVSP, LVEDP and ±dp/dt) were observed in isolated rat hearts after isehemia-reperfusion. RESULTS: Treatment with 10^-8 mol/L salusin-β significantly improved the post-ischemie CF, LVDP, LVEDP and ± dp/dt compared with those of the untreated hearts. The recovery of CF, LVDP, + dp/dt and dp/dt after reperfusion for 30 min was, respectively, (52±5)%, (79±8)%, (70±8)% and (69±10)% vs. (45±6)%, (68±10)%, (58±11)% and (57±8)% in control group (P 〈0. 01, n =8). In addition, in the presence of 10^-8 mol/L salusin-[3, LVEDP (28.25±7.62 ) mmHg improved significantly compared with that in control group (52. 52±11.27 ) mmHg. CONCLUSION: These results show that salusin-β alleviates isehemia-repeffusion injury and improves heart function.
出处 《心脏杂志》 CAS 2009年第5期648-651,共4页 Chinese Heart Journal
基金 国家自然科学基金项目资助(30600763和30800375)
关键词 salusin-β 心脏 缺血/再灌注 大鼠 salusin-β heart ischemia reperfusion
  • 相关文献

参考文献16

  • 1Shichiri M, Ishimaru S, Ota T, et al. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities[J]. Nat Med, 2003, 9(9):1166-1172.
  • 2Suzuki N, Shichiri M, Akashi T, et al. Systemic distribution of salusin expression in the rat [J]. Hypertens Res, 2007, 30(12):1255-1262.
  • 3Izumiyama H, Tanaka H, Egi K, et al. Synthetic salusins as cardiac depressors in rat [J]. Hypertension, 2005, 45(3):419-425.
  • 4Yu F, Zhao J, Yang J, et al. Salusins promote cardiomyocyte growth but does not affect cardiac function in rats[J]. Regul Pept, 2004, 122(3):191-197.
  • 5Takenoya F, Hori T, Kageyama H, et al. Coexistence of salusin and vasopressin in the rat hypothalamo-hypophyseal system[J]. Neurosci Lett, 2005, 385(2):110-113.
  • 6Xiao-Hong Y, Li L, Yan-Xia P, et al. Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78[J]. J Cardiovasc Pharmacol, 2006, 48(2):41-46.
  • 7Watanabe T, Nishio K, Kanome T, et al. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis[J]. Circulation, 2008, 117(5):638-648.
  • 8Watanabe T, Suguro T, Sato K, et al. Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients[J]. Hypertens Res, 2008, 31(3):463-468.
  • 9Di Lisa F. Mitochondrial contribution in the progression of cardiac ischemic injury[J]. IUBMB Life, 2001, 52(3-5):255-261.
  • 10Ferrari R, Guardigli G, Mele D, et al. Oxidative stress during myocardial ischaemia and heart failure[J]. Curr Pharm Des, 2004, 10(14):1699-1711.

同被引文献13

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部